Sunday , July 22 2018
Home / Production Assistant, Diabetes In Control (page 83)

Production Assistant, Diabetes In Control

Claude Lardinois Full Interview

Dr. Claude Lardinois talks with Diabetes in Control Associate Medical Editor Joy Pape at the 2016 AACE Meeting. Dr. Lardinois discusses amputations and SGLT-2s, and genetic risk factors for cardiovascular issues in diabetes patients. Dr. Claude Lardinois, M.D., FACP, FACE, MACN, has been an endocrinologist in Reno, Nevada for more …

Read More »

Diabetes Research Platform

Which party do you believe will be a champion for diabetes research, prevention, and treatment? 1) Democrats 2) Republicans 3) Independents 4) None of the above 5) Not sure Follow the link to share your opinion and see what your colleagues think.

Read More »

Question 857

Test Your Knowledge

The new class of drugs, SGLT-2 Inhibitors, have been shown to have positive results; which one is false? 1. Reduces BP 2. Reduces Uric Acid 3. Reduces Glucagon 4. Reduces Glucose 5. Reduces Oxidative Stress 6. Reduces Hypotension 7. Reduces HF Risk Did you get the right answer? Follow the link to find out!

Read More »

2nd Marriage Can Mean Expanded Family Obligations

It’s never too early to start talking about the holidays with our patients. For some, it’s a holiday almost every night. Man, 76 years of age, visits with his wife for obesity and type 2 diabetes management. Despite diabetes education, including medical nutritional therapy and medication, he was not losing weight nor were his glucose levels improving…especially his bedtime glucose levels.

Read More »

International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #47: Biosynthesis, secretion, and action of glucagon Part 1 of 4

Glucagon, discovered in 1923 as a contaminant of early insulin preparations, has long been a neglected hormone. Glucagon was among the very first polypeptide hormones to be isolated, purified, sequenced, and synthesized. Thanks to the pioneering work of Unger, it was the first polypeptide hormone to become measurable by radioimmunoassay, almost one year before insulin. It has served two Nobel Prize winners as a unique tool, which permitted Sutherland and his associates to discover cyclic AMP (cAMP), and Rodbell and his coworkers to discover the role of G-proteins in cell-membrane receptors.

Read More »